Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
| 2025-03-10 Sale | 2025-03-12 4:00 pm | Trevi Therapeutics Inc. | TRVI | Simon Farrell Chief Commercial Officer | 81,313 | $6.7502 | $548,878 | 145,237 (Direct) | View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
| 2025-03-10 Exercise | 2025-03-12 4:00 pm | N/A 2031-02-16 | Trevi Therapeutics Inc. | TRVI | Simon Farrell Chief Commercial Officer | 112,563 | $0 | 145,237 (Direct) | View |
| 2025-03-10 Option Award | 2025-03-12 4:00 pm | 2025-03-10 2034-02-14 | Trevi Therapeutics Inc. | TRVI | Simon Farrell Chief Commercial Officer | 38,400 | $0 | 145,237 (Direct) | View |
| 2025-03-10 Exercise | 2025-03-12 4:00 pm | N/A N/A | Trevi Therapeutics Inc. | TRVI | Simon Farrell Chief Commercial Officer | 63,813 | $3.91 | 145,237 (Direct) | View |
| 2025-03-10 Exercise | 2025-03-12 4:00 pm | N/A N/A | Trevi Therapeutics Inc. | TRVI | Simon Farrell Chief Commercial Officer | 31,250 | $0.511 | 145,237 (Direct) | View |
| 2025-03-10 Exercise | 2025-03-12 4:00 pm | N/A N/A | Trevi Therapeutics Inc. | TRVI | Simon Farrell Chief Commercial Officer | 17,500 | $3.21 | 145,237 (Direct) | View |
| 2025-02-18 Option Award | 2025-02-20 4:00 pm | N/A 2035-02-17 | Trevi Therapeutics Inc. | TRVI | Simon Farrell Chief Commercial Officer | 225,500 | $0 | 225,500 (Direct) | View |
| 2024-02-15 Option Award | 2024-02-16 4:43 pm | N/A 2034-02-14 | Trevi Therapeutics Inc. | TRVI | Simon Farrell Chief Commercial Officer | 175,000 | $0 | 175,000 (Direct) | View |
| 2023-06-20 Exercise | 2023-06-21 4:00 pm | N/A 2032-02-10 | Trevi Therapeutics Inc. | TRVI | Simon Farrell Chief Commercial Officer | 6,250 | $0 | 95,650 (Direct) | View |
| 2023-06-20 Exercise | 2023-06-21 4:00 pm | N/A N/A | Trevi Therapeutics Inc. | TRVI | Simon Farrell Chief Commercial Officer | 6,250 | $0.511 | 95,650 (Direct) | View |
| 2023-03-07 Exercise | 2023-03-08 4:00 pm | N/A 2032-02-10 | Trevi Therapeutics Inc. | TRVI | Simon Farrell Chief Commercial Officer | 18,750 | $0 | 95,650 (Direct) | View |
| 2023-03-07 Exercise | 2023-03-08 4:00 pm | N/A N/A | Trevi Therapeutics Inc. | TRVI | Simon Farrell Chief Commercial Officer | 18,750 | $0.511 | 95,650 (Direct) | View |
| 2023-02-16 Option Award | 2023-02-16 5:30 pm | N/A 2033-02-15 | Trevi Therapeutics Inc. | TRVI | Simon Farrell Chief Commercial Officer | 100,000 | $0 | 100,000 (Direct) | View |
Ownership | 2023-02-16 5:26 pm | N/A N/A | Trevi Therapeutics Inc. | TRVI | Simon Farrell Chief Commercial Officer | 0 | $0 | 188,150 (Direct) | View |